Detalles de la búsqueda
1.
The impact of proton-pump inhibitors administered with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma.
Anticancer Drugs;
34(1): 178-186, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36539370
2.
Management of brain metastases from lung cancer in the era of immunotherapy: a review of the literature.
Future Oncol;
17(5): 597-609, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33401981
3.
Myositis and myasthenia during nivolumab administration for advanced lung cancer: a case report and review of the literature.
Anticancer Drugs;
31(5): 540-544, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32011360
4.
Sequencing strategies in the new treatment landscape of prostate cancer.
Future Oncol;
15(25): 2967-2982, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31424285
5.
Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer.
Future Oncol;
15(10): 1115-1123, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30887825
6.
Abiraterone acetate and its use in the treatment of metastatic prostate cancer: a review.
Future Oncol;
14(5): 431-442, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29350549
7.
Enzalutamide after chemotherapy in advanced castration-resistant prostate cancer: the Italian Named Patient Program.
Future Oncol;
14(26): 2691-2699, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30207488
8.
Nasopharyngeal swab or clinical-radiological evidence: the dark side of the moon for cancer patients in the COVID-19 era.
Future Oncol;
16(19): 1321-1322, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32452225
9.
Impact of KRAS Mutations on Clinical Outcomes of Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer Receiving Anti-PD-1/PD-L1 Therapy.
Target Oncol;
18(1): 129-138, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36482151
10.
The role of mean corpuscular volume and red cell distribution width in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: the MARECAP retrospective study.
Ther Adv Urol;
15: 17562872231187216, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37492625
11.
Tailoring treatment with cabozantinib or pazopanib in patients with metastatic renal cell carcinoma: does it affect outcome?
Expert Rev Anticancer Ther;
23(5): 545-554, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37017710
12.
Integrating Red Blood Cell Features and Hemoglobin Levels in Metastatic Renal Cell Carcinoma Patients Treated with Pazopanib or Cabozantinib: An Easily Exploitable Prognostic Score.
Front Biosci (Elite Ed);
15(3): 20, 2023 07 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37743233
13.
Rheumatic immune-and nonimmune-related adverse events in phase 3 clinical trials assessing PD-(L)1 checkpoint inhibitors for lung cancer: A systematic review and meta-analysis.
Joint Bone Spine;
89(4): 105403, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35508288
14.
To treat or not to treat: is it acceptable to avoid active therapies in advanced prostate cancer today?
Expert Rev Anticancer Ther;
21(4): 389-400, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33245666
15.
Severe acute respiratory syndrome coronavirus 2 infection in patients with prostate cancer: A critical review.
Crit Rev Oncol Hematol;
167: 103491, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34626792
16.
Meta-analysis of immune-related adverse events in phase 3 clinical trials assessing immune checkpoint inhibitors for lung cancer.
Crit Rev Oncol Hematol;
162: 103351, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33989769
17.
Pretreatment lung immune prognostic index as a biomarker in advanced non-small-cell lung cancer patients receiving first line pembrolizumab.
Immunotherapy;
13(13): 1093-1103, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34190578
18.
Docetaxel and prednisone with or without enzalutamide as first-line treatment in patients with metastatic castration-resistant prostate cancer: CHEIRON, a randomised phase II trial.
Eur J Cancer;
155: 56-63, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34358777
19.
Role of circulating tumor DNA in the detection of sensitizing and resistance to epidermal growth factor receptor mutations in metastatic lung adenocarcinoma.
J BUON;
25(2): 848-854, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32521877
20.
Incidence and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with metastatic castration-resistant prostate cancer.
Eur J Cancer;
140: 140-146, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33091718